Historical record - last NADAC effective date: 4/22/2020
Product Information
OMEPRAZOLE DR 20 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0431 per EA under NDC 57237016101. Its NADAC has been published 143 times since Aug 9, 2017.
FDA first approved this application on Aug 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237016101
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
4/22/2020
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203270FDA Approved
8/19/2015
TE Code
AB
On Market Since
8/19/2015
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 20 MG CAPSULE has been published 143 times since Aug 9, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0431 per EA |
|---|---|
| All-time high | $0.0556 (Apr 11, 2018) |
| All-time low | $0.0381 (Feb 20, 2019) |
| Median price | $0.0419 |
| Average price | $0.0430 |
| Largest weekly change | +27.3% (Jan 17, 2018) |
| Weeks tracked | 143 |
| Tracking since | Aug 9, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+0.5%
Last surveyed Apr 29, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 20 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0431 per EA (NDC 57237016101), effective Apr 29, 2020.
How has the price of OMEPRAZOLE DR 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 20 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 143 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 20 MG CAPSULE?
Since Aug 9, 2017, the NADAC for OMEPRAZOLE DR 20 MG CAPSULE has ranged from a low of $0.0381 (Feb 20, 2019) to a high of $0.0556 (Apr 11, 2018), with a median of $0.0419 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 20 MG CAPSULE?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 20 MG CAPSULE, is $0.0277 per EA — about 36% below OMEPRAZOLE DR 20 MG CAPSULE.
Who manufactures OMEPRAZOLE DR 20 MG CAPSULE?
OMEPRAZOLE DR 20 MG CAPSULE (NDC 57237016101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.